Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

John V. Bosso, M.D., FAAAAI, FACAAI

Professor of Clinical Otorhinolaryngology: Head and Neck Surgery
Director, Otorhinolaryngology: HNS Allergy Clinic, Department of Otorhinolaryngolgy: Head and Neck Surgery at the Perelman Center for Advanced Medicine
Medical Director, Penn AERD Center, Department of Otorhinolaryngology: Head and Neck Surgery at the Perelman Center for Advanced Medicine
Department: Otorhinolaryngology: Head and Neck Surgery

Contact information
Hospital of the University of Pennsylvania
Perelman Center for Advanced Medicine
South Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-360-0372
Fax: 215-662-4613
Education:
B.S. (Biochemistry, summa cum laude)
Saint Peter's University, Jersey City, New Jersey, 1981.
M.D. (Medicine)
Jacobs School of Medicine, University at Buffalo, Buffalo, New York, 1985.
Post-Graduate Training
Internal Medicine Residency, SUNY Downstate at Staten Island University Hospital, 1985-1988.
Clinical Fellowship, Allergy/Immunology, Scripps Clinic and Research Foundation, La Jolla, California, 1988-1990.
Certifications
Diplomate, National Board of Medical Examiners , 1986.
Diplomate, American Board of Internal Medicine , 1988.
Diplomate, American Board of Allergy & Immunology, Actively participating in MOC, 1991.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

AERD/Samter's Triad
Chronic Rhinosinusitis
Nasal polyps
Aspirin/NSAID Allergy
Aspirin Desensitization
Biologicals for Asthma, CRS, Nasal Polyps
Immunotherapy for Allergic Diseases

Description of Research Expertise

AERD/Samter's Triad
Chronic Rhinosinusitis
Nasal polyps
Aspirin/NSAID Allergy
Aspirin Desensitization
Biologicals for Asthma, CRS, Nasal Polyps
Immunotherapy

Selected Publications

Michael T Werner, MD, Ph.D. and John V Bosso, MD: Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis. Allergy Asthma Proc. Joseph Bellanti and Russell Settipane (eds.). 42: 283-292, July 2021.

Civantos A, Maina I,Arnold M, Stevens EM, Tan L, Gleeson P, Cowart B, Bosso JV, Palmer JN, Adappa ND, Kohanski MA Cohen N. : Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups. International Forum of Allergy & Rhinology. Timothy Smith, MD (eds.). Wiley, June 2021.

Deng J, Tan LH, Kohanski MA, Kennedy DW, Bosso JV, Adappa ND, Palmer JN, Shi J, Cohen NA: "Solitary chemosensory cells are innervated by trigeminal nerve endings and autoregulated by cholinergic receptors" Int Forum Allergy Rhinol. Timothy Smith, MD (eds.). Wiley, 11(5): 877-884, May 2021.

Han JK, Bosso JV, Cho SH, Franzese C, Lam K, Lane AP, Lee SE, Palmer J, Peters A, Soler ZM, Lee JT.: Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. Timothy Smith, MD (eds.). Wiley, Page: 1-10, May 2021.

John V Bosso, MD : Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: Clinical perspective. Int Forum Allergy Rhinol. Timothy Smith, MD (eds.). Wiley, 11(4), April 2021.

Whitney W Stevens, Elina Jerschow, Alan P Baptist, Larry Borish, John V Bosso, Kathleen M Buchheit, Katherine N Cahill, Paloma Campo, Seong H Cho, Anjeni Keswani, Joshua M Levy, Anil Nanda, Tanya M Laidlaw, Andrew A White: The Role of Aspirin Desensitization Followed by Oral Aspirin Therapy in Managing Patients with Aspirin-Exacerbated Respiratory Disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma, and Immunology Journal of Allergy & Clinical Immunology Zuhair K. Ballas (eds.). Elsevier, 147(3): 827-844, Mar 2021.

Locke TB, Sweis AM, Douglas JE, Ig-Izevbekhai KI, Stevens EM, Civantos AM, McCarty EB, Kumar A, Kohanski MA, Kennedy DW, Palmer JN, Bosso JV, Adappa ND.: Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey. Am J Rhinol Allergy. Sage, March 2021.

Locke TB, Sweis AM, Douglas JE, Ig-Izevbekhai KI, Stevens EM, Civantos AM, McCarty EB, Kumar A, Kohanski MA, Kennedy DW, Palmer JN, Bosso JV, Adappa ND.: Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey. 2021 Mar 10:19458924211001640. Epub ahead of print. Am J Rhinol Allergy. Sage, March 2021.

John V Bosso, MD, Siddhant H Tripathi BS, David W kennedy MD, Michael A Kohanski MD, Noam A Cohen MDPhD, James N Palmer, MD and Nithin D Adappa, MD. : Multidisciplinary single-center outcomes compared to two-center outomes for the treatment of aspirin exacerbated repsiratory disease. J Allergy Clin Immunol in Pract. M Schatz, MD (eds.). Elsevier, Feb 2021.

Auddie M. Sweis MD, Tran B. Locke MD, Kevin I. Ig-Izevbekhai, BA, Theodore C. Lin BS, Patrick K. Gleeson MD, Alyssa M. Civantos BA, Ankur Kumar BS, Andrew Corr BA, Michael A. Kohanski MDPhD, James N. Palmer MD, John V. Bosso MD, Nithin D. Adappa MD : "Major Complications of Aspirin Desensitization and Maintenance Therapy in Aspirin Exacerbated Respiratory Disease" International Forum of Allergy & Rhinology. Timothy Smith, MD (eds.). Wiley, 11(2), Feb 2021 Notes: accepted for publication.

back to top
Last updated: 12/06/2021
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration